Use of Technetium-99m-Labeled Lipophilic Complex of Methoxy-Isobutyl-Isonitrile and Iopromide Radiopaque Substance to Assess the Severity of Coronary Atherosclerosis in Patients with Coronary Heart Disease at Mild Disorders of Myocardial Perfusion
| Parent link: | Advanced Materials Research : Radiation and nuclear techniques in material science: Scientific Journal Vol. 1084 : Physical-Technical Problems of Nuclear Science, Energy Generation, and Power Industry (PTPAI -2014).— 2015.— [P. 527-531] |
|---|---|
| Corporate Authors: | , |
| Other Authors: | , , , |
| Summary: | Title screen In this study we used technetium-99m-labeled lipophilic complex of methoxy-isobutyl-isonitrile ({99m}Tc-MIBI) and iopromide to assess coronary atherosclerosis in patients with coronary artery disease (CAD). The study included 33 patients with CAD who underwent myocardial perfusion scintigraphy with {99m}Tc-MIBI and computed tomography angiography (MDCTA) with iopromide. Patients who have comparable with the population-wide level risk of coronary events are characterized by the presence of borderline and significant stenosis 83% and 86%, respectively. {99m}Tc-MIBI and iopromide can be used to assess the severity of coronary atherosclerosis in patients with CAD. Режим доступа: по договору с организацией-держателем ресурса |
| Published: |
2015
|
| Series: | Radiation Technologies in Medicine |
| Subjects: | |
| Online Access: | http://dx.doi.org/10.4028/www.scientific.net/AMR.1084.527 |
| Format: | Electronic Book Chapter |
| KOHA link: | https://koha.lib.tpu.ru/cgi-bin/koha/opac-detail.pl?biblionumber=640437 |
| Summary: | Title screen In this study we used technetium-99m-labeled lipophilic complex of methoxy-isobutyl-isonitrile ({99m}Tc-MIBI) and iopromide to assess coronary atherosclerosis in patients with coronary artery disease (CAD). The study included 33 patients with CAD who underwent myocardial perfusion scintigraphy with {99m}Tc-MIBI and computed tomography angiography (MDCTA) with iopromide. Patients who have comparable with the population-wide level risk of coronary events are characterized by the presence of borderline and significant stenosis 83% and 86%, respectively. {99m}Tc-MIBI and iopromide can be used to assess the severity of coronary atherosclerosis in patients with CAD. Режим доступа: по договору с организацией-держателем ресурса |
|---|---|
| DOI: | 10.4028/www.scientific.net/AMR.1084.527 |